INVASIVE PNEUMOCOCCAL DISEASE AMONG INFECTED AND UNINFECTED CHILDREN OF MOTHERS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

Citation
Jj. Farley et al., INVASIVE PNEUMOCOCCAL DISEASE AMONG INFECTED AND UNINFECTED CHILDREN OF MOTHERS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of pediatrics, 124(6), 1994, pp. 853-858
Citations number
27
Categorie Soggetti
Pediatrics
Journal title
ISSN journal
00223476
Volume
124
Issue
6
Year of publication
1994
Pages
853 - 858
Database
ISI
SICI code
0022-3476(1994)124:6<853:IPDAIA>2.0.ZU;2-8
Abstract
Objective: To describe the incidence and clinical presentation of inva sive pneumococcal disease in a cohort of children infected with human immunodeficiency virus (HIV) who were prospectively followed from birt h, in comparison with uninfected children born to HIV-infected mothers and control children. Design: Prospective follow-up of a cohort recru ited at birth and born to mothers with known HIV status. The person-ye ars analysis method used the occurrence of invasive pneumococcal disea se as the end point. Setting: Hospital-based clinic specializing in ca re of HIV-at-risk and HIV-infected children in Baltimore, Md. Partici pants: Forty-one vertically HIV-infected children, 128 uninfected chil dren born to HIV-infected mothers, and 71 control children born to mot hers with negative findings for HIV but with HIV risk factors. Results : Among HIV-infected children, 10 episodes of invasive pneumococcal di sease occurred during the first 36 months of life compared with 4 epis odes among uninfected children and 1 episode among control subjects, T he relative risk for HIV-infected children versus the combined uninfec ted and control groups was 12.6 with a 95% confidence interval (5.4, 2 8.8) and a p value for difference between groups of <0.001. The incide nce rate per 100 child-years of observation during the first 36 months of life was 11.3 for HIV-infected, 1.1 for uninfected, and 0.5 for co ntrol children. Clinical and laboratory variables were not useful in i dentifying HIV-infected children at risk for pneumococcal disease. Con clusion: Practical strategies to prevent pneumococcal disease among HI V-infected children need to be developed.